Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Myovant Sciences's annualized positive value of Interest Expense for the quarter that ended in Mar. 2022 was $14.0 Mil. Myovant Sciences's average total debt for the quarter that ended in Mar. 2022 was $368.1 Mil. Therefore, Myovant Sciences's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2022 was 3.80%.
Myovant Sciences Effective Interest Rate on Debt % Historical Data
The historical data trend for Myovant Sciences's Effective Interest Rate on Debt % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Myovant Sciences Annual Data
Trend
Mar16
Mar17
Mar18
Mar19
Mar20
Mar21
Mar22
Effective Interest Rate on Debt %
4.69
12.34
11.23
4.19
3.79
Myovant Sciences Quarterly Data
Jun17
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Effective Interest Rate on Debt %
4.02
3.79
3.79
3.78
3.80
Competitive Comparison
For the Biotechnology subindustry, Myovant Sciences's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Myovant Sciences Effective Interest Rate on Debt % Distribution
For the Biotechnology industry and Healthcare sector, Myovant Sciences's Effective Interest Rate on Debt % distribution charts can be found below:
* The bar in red indicates where Myovant Sciences's Effective Interest Rate on Debt % falls into.
Myovant Sciences Effective Interest Rate on Debt % Calculation
Myovant Sciences's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Mar. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data,
the Interest Expense data used here is four times the quarterly (Mar. 2022) interest expense data.
Effective Interest Rate on Debt % is displayed in the 30-year financial page.
Myovant Sciences (NYSE:MYOV) Effective Interest Rate on Debt % Explanation
Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.
Myovant Sciences Effective Interest Rate on Debt % Related Terms
Thank you for viewing the detailed overview of Myovant Sciences's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.
Myovant Sciences Ltd is a healthcare company focused on redefining care for women and for men. The company's lead product candidate is relugolix, a once-daily, oral GnRH receptor antagonist. It has three late-stage clinical programs for relugolix in uterine fibroids, endometriosis, and prostate cancer. The company is also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, that has completed a Phase 2a study for the treatment of female infertility as part of assisted reproduction.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.41(4.07%) Volume: 491,528 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:MYOV has been successfully added to your 
